Healthcare provider profile · identity verified

Judith Shimer Stringfield, MD

Family Practice · WAYNESVILLE, NC · NPI 1699869701

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	305	103
Atorvastatin Calcium	Atorvastatin Calcium	152	71
Omeprazole	Omeprazole	133	46
Gabapentin	Gabapentin	131	37
Lisinopril	Lisinopril	127	50
Amlodipine Besylate	Amlodipine Besylate	113	40
Hydrochlorothiazide	Hydrochlorothiazide	107	39
Metformin Hcl	Metformin Hcl	107	45
Pantoprazole Sodium	Pantoprazole Sodium	106	41
Losartan Potassium	Losartan Potassium	100	39
Simvastatin	Simvastatin	97	43
Escitalopram Oxalate	Escitalopram Oxalate	96	31
Metoprolol Succinate	Metoprolol Succinate	96	39
Sertraline Hcl	Sertraline Hcl	89	32
Trazodone Hcl	Trazodone Hcl	83	26
Fluticasone Propionate	Fluticasone Propionate	78	33
Tramadol Hcl	Tramadol Hcl	71	22
Potassium Chloride	Potassium Chloride	69	17
Duloxetine Hcl	Duloxetine Hcl	67	15
Citalopram Hbr	Citalopram Hydrobromide	63	22
Pravastatin Sodium	Pravastatin Sodium	60	21
Eliquis	Apixaban	59	15
Albuterol Sulfate Hfa	Albuterol Sulfate	56	23
Alprazolam	Alprazolam	55	20
Montelukast Sodium	Montelukast Sodium	50	19
Bupropion Xl	Bupropion Hcl	49	13
Meloxicam	Meloxicam	45	14
Clonazepam	Clonazepam	44	suppressed
Glimepiride	Glimepiride	44	14
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Lorazepam	Lorazepam	42	11
Ozempic	Semaglutide	42	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	40	16
Rosuvastatin Calcium	Rosuvastatin Calcium	40	18
Zolpidem Tartrate	Zolpidem Tartrate	40	11
Atenolol	Atenolol	39	18
Azithromycin	Azithromycin	38	36
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Famotidine	Famotidine	37	14
Furosemide	Furosemide	35	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	13
Buspirone Hcl	Buspirone Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Clonidine Hcl	Clonidine Hcl	25	suppressed
Jardiance	Empagliflozin	23	suppressed
Amoxicillin	Amoxicillin	22	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	16
Synthroid	Levothyroxine Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Xarelto	Rivaroxaban	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Methylprednisolone	Methylprednisolone	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Prednisone	Prednisone	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Norethindrone	Norethindrone	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error